Tumor Necrosis Factor Production in B Cell Chronic Lymphocytic Leukemia

Area of Science:

• Immunology
• Oncology
• Hematology

Background:

• Tumor necrosis factor (TNF) is implicated as an autocrine growth factor in B cell malignancies.
• The specific role of TNFα in the progression of chronic lymphocytic leukemia (CLL) remains to be fully elucidated.

Purpose of the Study:

• To investigate the role of TNFα in relation to the clinical stage of chronic lymphocytic leukemia (CLL).
• To assess TNFα cytotoxic activity in stimulated and unstimulated peripheral blood mononuclear cells (PBMC) and malignant B cells from CLL patients at different disease stages.

Main Methods:

• Collected peripheral blood mononuclear cells (PBMC) and malignant B cells from chronic lymphocytic leukemia (CLL) patients at Rai stages 0 and IV.
• Stimulated cells with phytohemagglutinin (PHA) and bacterial lipopolysaccharide (LPS).
• Measured TNFα cytotoxic activity in conditioned media from stimulated and unstimulated cells and compared to normal PBMC controls.

Main Results:

• Peripheral blood mononuclear cells (PBMC) from stage IV CLL patients exhibited weak or absent responses to stimulation.
• Stimulation of stage 0 CLL PBMC induced significantly increased TNFα production.
• Unstimulated stage 0 PBMC and B cells spontaneously released excess TNFα compared to normal controls.
• No detectable TNFα activity was observed in unstimulated peripheral blood mononuclear cells (PBMC) or B cells from stage IV CLL patients.

Conclusions:

• These findings suggest a potential role for TNFα in the progression of chronic lymphocytic leukemia (CLL).
• Differential TNFα production based on disease stage indicates its involvement in CLL pathogenesis.